SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-22-000626
Filing Date
2022-05-12
Accepted
2022-05-12 16:01:04
Documents
14
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 GELESIS HOLDINGS, INC. 8-K a52717596.htm   iXBRL 8-K 29264
2 EXHIBIT 99.1 a52717596ex99_1.htm EX-99.1 299317
  Complete submission text file 0001157523-22-000626.txt   537010

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gls-20220512.xsd EX-101.SCH 4482
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gls-20220512_def.xml EX-101.DEF 18327
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gls-20220512_lab.xml EX-101.LAB 28498
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gls-20220512_pre.xml EX-101.PRE 20563
8 EXTRACTED XBRL INSTANCE DOCUMENT a52717596_htm.xml XML 6757
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39362 | Film No.: 22917629
SIC: 2834 Pharmaceutical Preparations